This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

11 Apr 2014

Kyowa Hakko Kirin Completes Construction of its Biopharmaceutical API Manufacturing Facility in the Takasaki Plant

Kyowa Hakko Kirin Co., Ltd  has completed the construction of the HA4 Plant (biopharmaceutical API manufacturing facility) at the Takasaki Plant in April 8, 2014.

The HA4 Plant has been installed as one of the largest bioreactors for recombinant animal cells (12,000 L bioreactor) in Japan, as well as a purification facility with a large column. By utilizing the manufacturing technology of biopharmaceutical products cultivated by the company, the company will realise a larger scale and stable manufacture, and continue to make efforts to provide the market with high-quality pharmaceutical products.

Related News